Cargando…
Non-conventional interactions of N3 inhibitor with the main protease of SARS-CoV and SARS-CoV-2
The extensive spread of COVID-19 in every continent shows that SARS-CoV-2 virus has a higher transmission rate than SARS-CoV virus which emerged in 2002. This results in a global pandemic that is difficult to control. In this investigation, we analyze the interaction of N3 inhibitor and the main pro...
Autores principales: | García-Gutiérrez, Ponciano, Zubillaga, Rafael A., Ibarra, Ilich A., Martínez, Ana, Vargas, Rubicelia, Garza, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357482/ https://www.ncbi.nlm.nih.gov/pubmed/34401047 http://dx.doi.org/10.1016/j.csbj.2021.08.015 |
Ejemplares similares
-
Copper(II) Inhibition of the SARS-CoV-2 Main Protease
por: Garza-López, Roberto A., et al.
Publicado: (2020) -
Activation and maturation of SARS-CoV main protease
por: Xia, Bin, et al.
Publicado: (2011) -
Developing inhibitors of the SARS-CoV-2 main protease
por: Seitz, Christian, et al.
Publicado: (2022) -
The SARS-CoV-2 main protease as drug target
por: Ullrich, Sven, et al.
Publicado: (2020) -
Topological analysis of SARS CoV-2 main protease
por: Estrada, Ernesto
Publicado: (2020)